Fwd: Call for Speakers: Medical Dermatology: Therapeutic R&D and Technical Innovation

[Kaamini]

Sent from iPhone

Begin forwarded message:

From: "Micah Lieberman" <ji...@healthtech.com>
Date: 18 March 2016 at 1:59:55 AM IST
To: mini.b...@gmail.com
Subject: Call for Speakers: Medical Dermatology: Therapeutic R&D and Technical Innovation

Dear Colleague: I am currently recruiting speakers for Cambridge Healthtech Institute's Inaugural Medical Dermatology: Therapeutic R&D and Technical Innovation conference taking place on November 2-4, 2016, in Philadelphia, PA. You are welcome to submit your proposed talk using the online proposal form by April 15, 2016. This conference provides a platform to discuss novel targets and disease pathways, advanced delivery technologies, new predictive and diagnostic technologies being utilized both in the clinic and for translational research, and the most promising emerging therapies. I am looking for novel speaking proposals from thought-leaders in their field and I look forward to your submission. Topics will include, but are not limited to: Current NMEs in Dermatology, Economic Outlook of Pipelines, & (ROI) of Dermatologic Drugs Novel Biologicals, Genomics, Antibodies, and Receptor-Ligand Antagonists for Dermatology New Insights into the Skin, the Immune System, & Inflammation of the Skin Insights into the Biology of Skin Disease Mechanisms: Promising Pathways Thinking about Skin Disease beyond the Drug Asset: Early Prediction, Dx and Monitoring Understanding Mechanisms, Novel Targets and Pathways in Inflammatory Skin Diseases (acne, rosacea, psoriasis, atopic dermatitis, eczema), Cancer and Pre-Cancers of the Skin (SCC, BCC, AK, non-melanoma), and Scleroderma and Other Orphan Skin Diseases Drug Discovery and Early Development in Inflammatory Skin Diseases, Cancer and Pre-Cancers of the Skin, and Orphan Skin Diseases Utilizing New Tech for Med Derm Research and Development: Biomarkers, Diagnostics, Imaging, Target Engagement, Skin Pharmacokinetics (PK) Drug Repurposing: Screening Current Assets with Related Indications and Mechanisms to find New Markets Repurposing Conventional Small Molecules and New Classes of Drugs: When to Develop, Partner, License Advanced Drug Delivery in Dermatological Drug Development Agents and Technologies, Drug Penetration and Vehicles Translational Research and Lessons from Clinicians: An Integrated Approach to Research, Development and Commercialization FDA, Payer, Patient Perspectives: Understanding Regulatory, Market Access, Value Drivers and Patient Perspectives Special Inclusive Half-Day Workshop on Friday: Optimizing Your Dermatological Drug Development: Understanding Intricacies of Developing Drugs in Dermatology Who should attend: Directors, Managers, Researchers, and Scientists from Pharma, Biotech, Academia, Regulatory, Government and Healthcare Organizations working in the area of Dermatology Researchers and Companies whose research and drug development in Oncology, Rheumatoid Arthritis, System Inflammation, Inflammatory Disease, Immunology, Ophthalmology crosses over into Dermatology Physicians and Clinicians involved in clinical and translational research in Dermatology CROs and CMOs with a focus on Dermatology, skin characterization techniques providers, formulation and manufacturing vendors, consultants Innovator Companies from Biotech-Pharma-Diagnostic, 505b2 Companies, and Small-Virtual Pharma working in Dermatological Drug Development Companies and individuals responsible for partnering, licensing, investment and business development in dermatology If you are interested in speaking, please submit a speaking proposal here. The deadline for submission is April 15, 2016. Not interested in speaking? Register here for a special early discounted rate and for group discounts. All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. For questions or suggestions about the meeting, please contact: Micah Lieberman Executive Director, Conferences Cambridge Healthtech Institute (CHI) T: (+1) 541.482.4709 E: mlieb...@healthtech.com For exhibit and partnering information, please contact: Terry Manning Business Development Manager Cambridge Healthtech Institute (CHI) T: (+1) 781.972.1349 E: tman...@healthtech.com For media and association partnerships, please contact: James Prudhomme Senior Marketing Manager Cambridge Healthtech Institute (CHI) T: (+1) 781.972.5486 E: jprud...@healthtech.com www.healthtech.com/dermatology Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, MA 02494 Tel: 781-972-5400 | Fax: 781-972-5425 | www.healthtech.com This email is being sent to mini.b...@gmail.com. This email communication is for marketing purposes. If it is not of interest to you, please disregard and we apologize for any inconvenience this may have caused. Visit www.chicorporate.com/corporate_unsubscibe.aspx to update usage.